Promoting Maternal-Infant Survival Everywhere (PROMISE)

This documentation is specific to PROMISE and does not apply to other projects. If you are looking for information about using LDMS, view our documentation

Memos

• 19-Mar-2015: VQA HIV RNA Copy Control (200 copies/mL) Change in Control Range
• 05-Nov-2014: LDMS Condition Code Usage
• 04-Nov-2011: Change of Viable PBMC Shipping in IMPAACT
• 29-Sep-2011: Required use of the VQA 200 cp/ml control
• 16-May-2011: VQA HIV RNA Copy Control, Change in Control Range
• 30-Dec-2010: Cryopreservation Certification Requirements
• 17-Dec-2010: VQA HIV RNA Copy Control Implementation Plan
• 10-Nov-2010: Mandate for use of LDMS Storage Module
• 23-Aug-2010: Mandate for use of LDMS Storage Module and PBMC Processing Tracking Fields
• 15-Jan-2009: Required Use of LDMS for Submitting HIV-1 RNA Viral Load and DNA PCR Results
• 13-Aug-2008: ACTG and IMPAACT Bar Coding Implementation
• 02-May-2008: Specimen Destruction for ACTG Non-Priority Protocols
• 03-Mar-2004: Storage of Specimens Collected for AACTG Protocols Less than ACTG 300

Assay Instructions

• COBAS Ampliprep/COBAS TaqMan HIV-1 Qualitative Test
• Abbott Realtime HIV-1
• COBAS TaqMan HCV
• COBAS TaqMan HIV-1
• Running DNA Assays in LDMS

Using LDMS

• LDMS Transaction Log Reference Guide
• Condition Code Scenarios and Solutions
• Condition Code Workflow Diagram
• IQA Cryopreservation Panel Procedure
• Entering and Resulting PK Controls